SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-002232
Filing Date
2020-03-09
Accepted
2020-03-09 16:08:21
Documents
88
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K crvs-20191231x10k.htm 10-K 3843315
2 EX-4.5 crvs-20191231ex45adb3c49.htm EX-4.5 53977
3 EX-10.16(B) crvs-20191231ex1016b82ec.htm EX-10.16(B) 22083
4 EX-10.16(C) crvs-20191231ex1016cdf22.htm EX-10.16(C) 28073
5 EX-10.17(B) crvs-20191231ex1017b16cd.htm EX-10.17(B) 21917
6 EX-10.18 crvs-20191231ex1018cd3ce.htm EX-10.18 272648
7 EX-23.1 crvs-20191231ex23136b88e.htm EX-23.1 2412
8 EX-31.1 crvs-20191231ex311da44ef.htm EX-31.1 17976
9 EX-31.2 crvs-20191231ex312bc6e82.htm EX-31.2 18743
10 EX-32.1 crvs-20191231ex3210c2734.htm EX-32.1 9857
11 GRAPHIC crvs20191231ex1018cd3ce001.jpg GRAPHIC 2148
12 GRAPHIC crvs20191231x10k001.jpg GRAPHIC 98283
13 GRAPHIC crvs20191231x10k002.jpg GRAPHIC 23627
14 GRAPHIC crvs20191231x10k003.jpg GRAPHIC 45975
  Complete submission text file 0001558370-20-002232.txt   11390528

Data Files

Seq Description Document Type Size
15 EX-101.INS crvs-20191231.xml EX-101.INS 2302031
16 EX-101.SCH crvs-20191231.xsd EX-101.SCH 55570
17 EX-101.CAL crvs-20191231_cal.xml EX-101.CAL 66768
18 EX-101.DEF crvs-20191231_def.xml EX-101.DEF 159359
19 EX-101.LAB crvs-20191231_lab.xml EX-101.LAB 531748
20 EX-101.PRE crvs-20191231_pre.xml EX-101.PRE 367879
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37719 | Film No.: 20698037
SIC: 2834 Pharmaceutical Preparations